The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.30BCNY
494.23M · vs all stocks (USD)
Updated Oct 23, 2026
Trailing P/E
101.29x
vs Medical Devices peers
Updated Oct 23, 2026
Revenue (TTM)
371.61MCNY
55.73M · vs all stocks (USD)
Updated Oct 23, 2026
Profit Margin
8.84%
vs Medical Devices peers
Updated Oct 23, 2026
Beta
0.7080x
vs all stocks
Updated Oct 23, 2026
52-Week Change
19.36%
vs all stocks
Updated Oct 23, 2026
Market Capitalization
3.30BCNY
494.23M · vs all stocks (USD)
Updated Oct 23, 2026
Enterprise Value
3.50BCNY
525.41M · vs all stocks (USD)
Updated Oct 23, 2026
Trailing P/E
101.29x
vs Medical Devices peers
Updated Oct 23, 2026
Forward P/E
39.15x
vs Medical Devices peers
Updated Oct 23, 2026
Price to Sales (TTM)
8.90x
vs Medical Devices peers
Updated Oct 23, 2026
Price to Book (MRQ)
2.98x
vs Medical Devices peers
Updated Oct 23, 2026
Enterprise to Revenue
9.43x
vs Medical Devices peers
Updated Oct 23, 2026
Enterprise to EBITDA
74.64x
vs Medical Devices peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 41.58×.Updated Oct 23, 2026
Gross Margin
39.68%
vs Medical Devices peers
Updated Oct 23, 2026
Profit Margin
8.84%
vs Medical Devices peers
Updated Oct 23, 2026
Operating Margin
5.12%
vs Medical Devices peers
Updated Oct 23, 2026
Return on Assets (TTM)
0.87%
vs Medical Devices peers
Updated Oct 23, 2026
Return on Equity (TTM)
2.50%
vs Medical Devices peers
Updated Oct 23, 2026
Revenue (TTM)
371.61MCNY
55.73M · vs all stocks (USD)
Updated Oct 23, 2026
Revenue per Share (TTM)
2.62CNYUpdated Oct 23, 2026
Quarterly Revenue Growth
33.30%
vs Medical Devices peers
Updated Oct 23, 2026
Gross Profit (TTM)
148.32MCNY
22.24M · vs all stocks (USD)
Updated Oct 23, 2026
EBITDA (TTM)
84.24MCNY
12.64M · vs all stocks (USD)
Updated Oct 23, 2026
Net Income (TTM)
32.86MCNY
4.93M · vs all stocks (USD)
Updated Oct 23, 2026
Quarterly Earnings Growth (YoY)
130.70%
vs Medical Devices peers
Updated Oct 23, 2026
Operating Cash Flow (TTM)
27.09MCNY
4.06M · vs all stocks (USD)
Updated Oct 23, 2026
Levered Free Cash Flow (TTM)
-4.73MCNY
-710.10K · vs all stocks (USD)
Updated Oct 23, 2026
5-Year Average Dividend Yield
0.34%
vs all stocks
Updated Oct 23, 2026
Payout Ratio
0.00%
vs Medical Devices peers
Updated Oct 23, 2026
Minority Interest (Equity)
83.28MCNYFY2025 · Dec 31, 2025
Revenue
345.49MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
194.58MCNYFY2025 · Dec 31, 2025
Gross Profit
150.90MCNYFY2025 · Dec 31, 2025
Operating Income
58.21MCNY
8.73M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
31.53MCNYFY2025 · Dec 31, 2025
Income Tax Expense
5.80MCNYFY2025 · Dec 31, 2025
Net Income
25.73MCNYFY2025 · Dec 31, 2025
EBIT
35.51MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
84.24MCNYFY2025 · Dec 31, 2025
Research & Development
21.73MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
25.48MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
5.13MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
255.05KCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
3.99MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.2300CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.2300CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
133.84MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
133.84MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
25.73MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
5.05MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
39.07MCNYFY2025 · Dec 31, 2025
Free Cash Flow
14.60MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
185.69MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
25.73MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
5.80MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
5.30MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
2.24MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-24.47MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-3.36MCNYFY2025 · Dec 31, 2025
Sale of Investments
61.85KCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-27.77MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
163.10MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-164.25MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-3.99MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-100.00KCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-5.24MCNYFY2025 · Dec 31, 2025
Shares Outstanding
136.00MSharesUpdated Oct 23, 2026
Float Shares
67.65MSharesUpdated Oct 23, 2026
% Held by Insiders
50.82%
vs all stocks
Updated Oct 23, 2026
% Held by Institutions
2.47%
vs all stocks
Updated Oct 23, 2026
Total Cash (MRQ)
70.55MCNY
10.58M · vs all stocks (USD)
Updated Oct 23, 2026
Total Cash per Share (MRQ)
0.5190CNYUpdated Oct 23, 2026
Total Debt (MRQ)
163.46MCNY
24.52M · vs all stocks (USD)
Updated Oct 23, 2026
Total Debt to Equity (MRQ)
0.1346x
vs Medical Devices peers
Updated Oct 23, 2026
Current Ratio (MRQ)
2.57x
vs Medical Devices peers
Updated Oct 23, 2026
Book Value per Share (MRQ)
8.16CNYUpdated Oct 23, 2026
Total Assets
1.50BCNY
224.89M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
757.15MCNYFY2025 · Dec 31, 2025
Total Liabilities
313.25MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
742.31MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
3.86MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
309.39MCNYFY2025 · Dec 31, 2025
Cash
185.69MCNYFY2025 · Dec 31, 2025
Cash Equivalents
533.82KCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
186.22MCNYFY2025 · Dec 31, 2025
Accounts Receivable
401.04MCNYFY2025 · Dec 31, 2025
Inventory
92.11MCNYFY2025 · Dec 31, 2025
Accounts Payable
102.46MCNYFY2025 · Dec 31, 2025
Short-term Debt
125.10MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
13.73MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
136.00MCNYFY2025 · Dec 31, 2025
Retained Earnings
568.63MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.19BCNY
177.91M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
18.15CNYUpdated Oct 23, 2026
52-Week High
36.58CNYUpdated Oct 23, 2026
52-Week Change
19.36%
vs all stocks
Updated Oct 23, 2026
Beta
0.7080x
vs all stocks
Updated Oct 23, 2026
50-Day MA
25.41CNYUpdated Oct 23, 2026
200-Day MA
24.50CNYUpdated Oct 23, 2026
Avg 10-Day Volume
1.98MSharesUpdated Oct 23, 2026
Avg 30-Day Volume
1.75MSharesUpdated Oct 23, 2026
Diluted EPS (TTM)
0.2400CNYUpdated Oct 23, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
High Retained Earnings With Profitability And Equity
Profits kept in the business fund much of what it owns, after five straight profitable years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.